These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16972535)

  • 1. [Controversies in judgment criteria of cardiovascular prevention studies].
    Scheen AJ
    Rev Med Suisse; 2006 Aug; 2(76):1875-6. PubMed ID: 16972535
    [No Abstract]   [Full Text] [Related]  

  • 2. [Omega-3-fatty acids still beneficial in cardiovascular disease].
    Landmark K; Aursnes I; Reikvam A; Alm CS
    Tidsskr Nor Laegeforen; 2007 Jan; 127(2):202-3. PubMed ID: 17237871
    [No Abstract]   [Full Text] [Related]  

  • 3. What we really need to do to reduce cardiovascular events in hypertensive patients.
    Ong HT
    J Fam Pract; 2007 Sep; 56(9):727-34. PubMed ID: 17764644
    [No Abstract]   [Full Text] [Related]  

  • 4. [Presentation: European practice guidelines for the prevention of cardiovascular diseases in clinical practice].
    Di Pasquale G
    G Ital Cardiol (Rome); 2008 Jan; 9(1):9-10. PubMed ID: 18383762
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reply concerning the new Medical Products Agency's guidelines for primary prevention of cardiovascular diseases. Issuing recommendations based on available evidence basis an ethical duty].
    Beermann B
    Lakartidningen; 2006 Nov 22-28; 103(47):3731-2. PubMed ID: 17212324
    [No Abstract]   [Full Text] [Related]  

  • 6. [The Medical Products Agency's new guidelines for primary prevention of cardiovascular diseases. No help to physicians].
    Berglund G
    Lakartidningen; 2006 Nov 22-28; 103(47):3694-5. PubMed ID: 17212315
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 8. Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials.
    Trifirò G; Alacqua M; Corrao S; Tari M; Arcoraci V
    J Am Geriatr Soc; 2008 Jan; 56(1):175-7. PubMed ID: 18184214
    [No Abstract]   [Full Text] [Related]  

  • 9. [Acetylsalicylic acid does not prevent cardiovascular disease. Poor scientific support for therapeutic guidelines according to primary prevention studies].
    Mooe T
    Lakartidningen; 2006 Sep 20-26; 103(38):2732-6. PubMed ID: 17058766
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiplatelet therapy and cardiovascular primary prevention: influence of gender, age and other risk factors.
    Sousa CS; Fonseca T; Clara JG
    Rev Port Cardiol; 2008 Apr; 27(4):513-27. PubMed ID: 18605070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cardiovascular prevention in the over-80 age group is not beneficial].
    de Ruijter W; Gussekloo J
    Ned Tijdschr Geneeskd; 2008 Jan; 152(1):27. PubMed ID: 18240758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Time for a European perspective on cardiovascular prevention].
    Nilsson PM; Perk J; Rydén L
    Lakartidningen; 2008 Apr 2-8; 105(14):1000-4. PubMed ID: 18478749
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular disease on a global scale: defining the path forward for research and practice.
    Mark DB; Van de Werf FJ; Simes RJ; White HD; Wallentin LC; Califf RM; Armstrong PW;
    Eur Heart J; 2007 Nov; 28(21):2678-84. PubMed ID: 17940081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preventing cardiovascular disease in type 2 diabetes. From evidence based medicine to patient based reality].
    Arnold-Kunz G; Ruiz J
    Rev Med Suisse; 2007 Jun; 3(114):1456-8, 1460-2. PubMed ID: 17639667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What future for cardiovascular prevention trials?].
    Scheen AJ
    Rev Med Suisse; 2009 Aug; 5(214):1635-6. PubMed ID: 19772193
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trials and clinical judgment.
    DeMaria AN
    J Am Coll Cardiol; 2008 Mar; 51(11):1120-2. PubMed ID: 18342233
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trials of antioxidant supplementation in the prevention of cardiovascular events.
    Katsiki N; Manes C
    Arch Intern Med; 2008 Apr; 168(7):773; author reply 773-4. PubMed ID: 18413563
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating the evidence: is there a rigid hierarchy?
    Ho PM; Peterson PN; Masoudi FA
    Circulation; 2008 Oct; 118(16):1675-84. PubMed ID: 18852378
    [No Abstract]   [Full Text] [Related]  

  • 19. The future of postmenopausal hormone therapy: It's time to move forward.
    Speroff L
    Maturitas; 2007 May; 57(1):103-6. PubMed ID: 17368975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevention of cardiovascular disease: have we really made progress?
    Pearson TA
    Health Aff (Millwood); 2007; 26(1):49-60. PubMed ID: 17211013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.